In the HT treatment, we found that the maximum velocity of RuBP carboxylation by Rubisco ( V cmax ) and the maximum potential rate of electron transport contributing to RuBP regeneration ( J max ) also dropped significantly compared to the NT treatment (from 47.30 (NT) to 20.42 mol m 2 s 1 (HT) and from 126.63 (NT) to 45.51 mol m 2 s 1 (HT), respectively)
[Crossref] [Google Scholar] [PubMed] Polyakova V, Loeffler I, Hein S, Miyagawa S, Piotrowska I, Dammer S, et al
PSM appreciates Ohio's vigilance in protecting patient safety in this under-regulated area: you can see their 2025 list of suspensions here, and read explanations of cases here
Relationship between the clinical state and intrathyroidal iodine as measured in vivo in man
But it has not been ruled out, and the FDA's briefing documents noted it as an uncharacterized risk requiring further investigation before any approval
Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists
